UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026137
Receipt number R000030035
Scientific Title Intravenous versus combined intravenous and intra-articular tranexamic acid for simultaneous bilateral total knee arthroplasty: randomized controlled trial
Date of disclosure of the study information 2017/02/14
Last modified on 2019/10/23 23:41:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Intravenous versus combined intravenous and intra-articular tranexamic acid for simultaneous bilateral total knee arthroplasty: randomized controlled trial

Acronym

Intravenous versus combined intravenous and intra-articular tranexamic acid for simultaneous bilateral TKA: randomized controlled trial

Scientific Title

Intravenous versus combined intravenous and intra-articular tranexamic acid for simultaneous bilateral total knee arthroplasty: randomized controlled trial

Scientific Title:Acronym

Intravenous versus combined intravenous and intra-articular tranexamic acid for simultaneous bilateral TKA: randomized controlled trial

Region

Japan


Condition

Condition

Osteoarthritis of the knee
Rheumatoid arthritis

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate whether combined intravenous and intra-articular administration of tranexamic acid reduced perioperative blood loss compared with intravenous-only administration of tranexamic acid for the patients undergoing simultaneous bilateral total knee arthroplasty.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The volume of perioperative blood loss measured using the calculated blood volume and change in hemoglobin from preoperative to postoperative day 3

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

The combined tranexamic acid group received 1000 mg of tranexamic acid administered intravenously just before skin incision of the first knee. After closure of the capsule and retinaculum, 1000 mg of tranexamic acid (10 mL of 100 mg/mL tranexamic acid) was administered intra-articularly for each knee. Six hours after the first intravenous administration of tranexamic acid, 1000 mg of tranexamic acid was again given intravenously.

Interventions/Control_2

The intravenous tranexamic acid group received 1000 mg of tranexamic acid administered intravenously just before skin incision of the first knee. After closure of the capsule and retinaculum, 10 mL of normal saline was administered intra-articularly for each knee. Six hours after the first intravenous administration of tranexamic acid, 1000 mg of tranexamic acid was again given intravenously.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients undergoing simultaneous bilateral total knee arthroplasty

Key exclusion criteria

Known allergic reaction to tranexamic acid
Patients with preoperative hemoglobin level < 11.0 g/dL
Refusal of blood products
Enrollment in another interventional clinical trial within 6 months prior to surgery

Target sample size

32


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Sachiyuki Tsukada

Organization

Hokusuikai Kinen Hospital

Division name

Orthopaedic Surgery

Zip code


Address

3-2-1 Higashihara, Mito, Ibaraki 310-0035, Japan

TEL

0293033003

Email

s8058@nms.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Sachiyuki Tsukada

Organization

Hokusuikai Kinen Hospital

Division name

Orthopaedic Surgery

Zip code


Address

3-2-1 Higashihara, Mito, Ibaraki 310-0035, Japan

TEL

0293033003

Homepage URL


Email

s8058@nms.ac.jp


Sponsor or person

Institute

Hokusuikai Kinen Hospital

Institute

Department

Personal name



Funding Source

Organization

Hokusuikai Kinen Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 02 Month 14 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/s12891-019-2890-8

Number of participants that the trial has enrolled

77

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 02 Month 14 Day

Date of IRB


Anticipated trial start date

2017 Year 02 Month 15 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 02 Month 14 Day

Last modified on

2019 Year 10 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030035


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name